926:
764:
182:
445:
424:
455:
754:
733:
166:
1039:
333:
665:
892:
644:
284:
1491:
254:
393:
554:
533:
564:
954:
1536:
842:
237:
938:
159:
174:
995:
1430:
1562:
Authorizations . . . On 5 May 2021, EMA's human medicines committee (CHMP) has started a rolling review of the vaccine. The EU applicant for this medicine is the
Italian company Life'On S.r.l.
1356:
are both good alternative titles, and I am relisting so the discussion can be more focused on which of the two potential suggestions I just listed would be a better title for the page. Thanks!
1519:
195:
1666:
68:
1606:
989:
582:
1676:
964:
586:
208:
1565:
There is no ongoing EMA Rolling Review for
Sinopharm BIBP-CorV. The information stated in literature reference 84 relates to the vaccine CoronaVac from SinoVac. --
1661:
1118:
810:
245:
241:
1646:
715:
705:
299:
477:
1651:
103:
1631:
1616:
1180:
1008:
626:
616:
515:
505:
1656:
1636:
681:
1641:
1621:
820:
109:
1094:
Subsequent comments should be made in a new section on the talk page. Editors desiring to contest the closing decision should consider a
1671:
1426:
1386:
591:
481:
1681:
1626:
1611:
1434:
1250:
672:
649:
1523:
1245:
would be more more consistent with how other vaccines are named within
Knowledge. No need to split up the two parts of each name.
1174:
1406:
1053:
786:
215:
1455:
1451:
1353:
1349:
1267:
1263:
1242:
1238:
1110:
1106:
1063:
1059:
123:
54:
48:
1023:
577:
538:
468:
429:
128:
44:
1477:
Subsequent comments should be made on the appropriate discussion page. No further edits should be made to this discussion.
1328:
1288:
1271:
1246:
908:
862:
98:
1547:
919:
877:
404:
318:
291:
222:
777:
738:
370:
89:
1152:
1143:
1049:
904:
858:
785:
related articles on
Knowledge. If you would like to participate, please visit the project page, where you can join
314:
253:
232:
1167:
1085:
1045:
374:
264:
201:
150:
1570:
1543:
1497:
1336:
133:
1463:
866:
306:
317:
may be blocked or restricted by an administrator. Editors are advised to familiarise themselves with the
1566:
1375:
1095:
410:
1332:
1003:
1584:
392:
189:
1588:
1098:
after discussing it on the closer's talk page. No further edits should be made to this discussion.
378:
310:
79:
680:
on
Knowledge. If you would like to participate, please visit the project page, where you can join
1410:
1390:
1315:
1211:
1159:
1124:
269:
94:
454:
444:
423:
1592:
1574:
1551:
1527:
1467:
1459:
1438:
1418:
1398:
1379:
1362:
1340:
1319:
1295:
1280:
1254:
1227:
1132:
753:
732:
75:
1371:
1163:
332:
266:
268:
1358:
1223:
891:
569:
460:
341:
969:
1600:
1311:
1207:
664:
643:
283:
1276:
769:
677:
17:
1139:
759:
559:
450:
1199:
1148:
369:) and some terms that are used in it may be different or absent from other
1202:. If this request is approved, then naturally WIBP-CorV would be moved to
473:
295:
149:
1518:
change "emergency used authorization" to "emergency use authorization"
1270:. I have no problems with the current title, but if I have to choose,
1017:
984:
930:
865:. Specific illustrations, plots or diagrams can be requested at the
1580:
Antibody
Response to Sinopharm COVID-19 Vaccine in Cancer Patients:
953:
553:
532:
782:
476:-related articles. If you would like to help, you are invited to
589:. Please visit the project page for details or ask questions at
841:
165:
1485:
1033:
948:
886:
836:
386:
327:
278:
270:
39:
26:
581:, which recommends that medicine-related articles follow the
962:
for
Knowledge's health content are defined in the guideline
890:
840:
305:
Editors who repeatedly or seriously fail to adhere to the
173:
1044:
On 12 August 2021, it was proposed that this article be
294:
procedure applies to this page. This page is related to
781:, a collaborative effort to improve the coverage of
676:, a collaborative effort to improve the coverage of
1115:per discussion consensus and consistency policies.
1009:
clinical publications about evidence-based medicine
965:Knowledge:Identifying reliable sources (medicine)
472:, a project to coordinate efforts to improve all
1667:C-Class China-related articles of Mid-importance
1482:Semi-protected edit request on 10 September 2021
57:for general discussion of the article's subject.
585:and that biomedical information in any article
583:Manual of Style for medicine-related articles
221:
181:
8:
1607:Knowledge articles that use British English
1429:has also been notified of this discussion.
1084:The following is a closed discussion of a
727:
638:
527:
418:
345:, which has its own spelling conventions (
1677:Knowledge requested biochemistry diagrams
1409:has been notified of this discussion. Â â
1389:has been notified of this discussion. Â â
929:may be able to locate suitable images on
990:review articles from the past five years
729:
640:
529:
420:
390:
1431:2409:4061:700:93AF:418E:4466:2FDB:DC48
1662:Mid-importance China-related articles
1520:2001:EE0:1A1:5484:7280:4C94:88BE:3F67
1194:. English-speaking media mostly uses
377:, this should not be changed without
207:
7:
1647:Mid-importance pharmacology articles
1103:The result of the move request was:
1018:Centre for Reviews and Dissemination
775:This article is within the scope of
670:This article is within the scope of
575:This article is within the scope of
466:This article is within the scope of
298:, broadly construed, which has been
1348:there seems to be a consensus that
1274:'s suggestion the best way to go. â
592:Knowledge talk:WikiProject Medicine
47:for discussing improvements to the
690:Knowledge:WikiProject Pharmacology
25:
1652:WikiProject Pharmacology articles
1015:Other potential sources include:
693:Template:WikiProject Pharmacology
1632:Mid-importance medicine articles
1617:Mid-importance COVID-19 articles
1534:
1489:
1473:The discussion above is closed.
1037:
952:
762:
752:
731:
663:
642:
587:use high-quality medical sources
562:
552:
531:
453:
443:
422:
391:
331:
282:
252:
69:Click here to start a new topic.
1456:Sinopharm WIBP COVID-19 vaccine
1452:Sinopharm BIBP COVID-19 vaccine
1354:Sinopharm WIBP COVID-19 vaccine
1350:Sinopharm BIBP COVID-19 vaccine
1308:Sinopharm WIBP COVID-19 vaccine
1304:Sinopharm BIBP COVID-19 vaccine
1268:Sinopharm WIBP COVID-19 vaccine
1264:Sinopharm BIBP COVID-19 vaccine
1243:Sinopharm WIBP COVID-19 vaccine
1239:Sinopharm BIBP COVID-19 vaccine
1204:Sinopharm COVID-19 vaccine WIBP
1153:Sinopharm COVID-19 vaccine WIBP
1144:Sinopharm COVID-19 vaccine BIBP
1111:Sinopharm WIBP COVID-19 vaccine
1107:Sinopharm BIBP COVID-19 vaccine
1064:Sinopharm WIBP COVID-19 vaccine
1060:Sinopharm BIBP COVID-19 vaccine
1050:Sinopharm COVID-19 vaccine BIBP
978:Sinopharm BIBP COVID-19 vaccine
914:For more information, refer to
872:For more information, refer to
815:This article has been rated as
710:This article has been rated as
621:This article has been rated as
510:This article has been rated as
49:Sinopharm BIBP COVID-19 vaccine
1657:C-Class China-related articles
1637:All WikiProject Medicine pages
1552:04:59, 11 September 2021 (UTC)
1528:18:14, 10 September 2021 (UTC)
1214:) 20:27, 12 August 2021 (UTC)
601:Knowledge:WikiProject Medicine
490:Knowledge:WikiProject COVID-19
409:It is of interest to multiple
1:
1642:C-Class pharmacology articles
1622:WikiProject COVID-19 articles
1077:Requested move 12 August 2021
976:sources of information about
789:and see a list of open tasks.
684:and see a list of open tasks.
604:Template:WikiProject Medicine
493:Template:WikiProject COVID-19
319:contentious topics procedures
66:Put new text under old text.
1575:19:38, 2 February 2022 (UTC)
1198:, ignoring the existence of
1512:to reactivate your request.
1500:has been answered. Set the
1468:18:23, 22 August 2021 (UTC)
1439:19:20, 21 August 2021 (UTC)
1419:02:05, 20 August 2021 (UTC)
1399:02:04, 20 August 2021 (UTC)
1380:01:23, 22 August 2021 (UTC)
1363:21:16, 19 August 2021 (UTC)
1341:23:00, 14 August 2021 (UTC)
1320:15:30, 14 August 2021 (UTC)
1296:13:23, 14 August 2021 (UTC)
1255:03:30, 14 August 2021 (UTC)
1228:21:16, 19 August 2021 (UTC)
1133:15:22, 26 August 2021 (UTC)
795:Knowledge:WikiProject China
74:New to Knowledge? Welcome!
1698:
1672:WikiProject China articles
920:Knowledge:Requested images
878:Knowledge:Requested images
821:project's importance scale
798:Template:WikiProject China
716:project's importance scale
627:project's importance scale
516:project's importance scale
1682:Knowledge requested logos
1627:C-Class medicine articles
1612:C-Class COVID-19 articles
1168:World Health Organization
814:
747:
709:
658:
620:
547:
509:
438:
417:
321:before editing this page.
104:Be welcoming to newcomers
33:Skip to table of contents
1475:Please do not modify it.
1329:John P. Sadowski (NIOSH)
1272:John P. Sadowski (NIOSH)
1247:John P. Sadowski (NIOSH)
1091:Please do not modify it.
673:WikiProject Pharmacology
315:normal editorial process
32:
1593:16:40, 2 May 2024 (UTC)
916:discussion on this page
899:It is requested that a
874:discussion on this page
849:It is requested that a
302:as a contentious topic.
1370:per John P. Sadowski--
927:Free Image Search Tool
918:and/or the listing at
895:
876:and/or the listing at
845:
801:China-related articles
480:and to participate in
399:This article is rated
311:standards of behaviour
99:avoid personal attacks
894:
844:
696:pharmacology articles
246:Auto-archiving period
147:Find medical sources:
124:Neutral point of view
1450:moving the pages to
1427:WikiProject Medicine
1387:WikiProject COVID-19
996:free review articles
972:. Here are links to
933:and other web sites.
851:biochemistry diagram
578:WikiProject Medicine
469:WikiProject COVID-19
375:relevant style guide
371:varieties of English
307:purpose of Knowledge
129:No original research
909:improve its quality
907:in this article to
863:improve its quality
861:in this article to
482:project discussions
373:. According to the
1544:Extraordinary Writ
1346:Relisting comment:
968:and are typically
896:
846:
405:content assessment
292:contentious topics
153:
110:dispute resolution
71:
1558:Wrong information
1516:
1515:
1441:
1421:
1407:WikiProject China
1401:
1310:seem ok to me. --
1291:
1287:
1283:
1230:
1206:for consistency.
1196:Sinopharm vaccine
1122:
1119:non-admin closure
1071:
1070:
1032:
1031:
947:
946:
934:
923:
885:
884:
881:
835:
834:
831:
830:
827:
826:
778:WikiProject China
726:
725:
722:
721:
637:
636:
633:
632:
607:medicine articles
526:
525:
522:
521:
496:COVID-19 articles
385:
384:
326:
325:
277:
276:
152:Source guidelines
151:
90:Assume good faith
67:
38:
37:
16:(Redirected from
1689:
1542:
1538:
1537:
1507:
1503:
1493:
1492:
1486:
1424:
1416:
1413:
1404:
1396:
1393:
1384:
1361:
1312:Fernando Trebien
1294:
1289:
1285:
1281:
1226:
1215:
1208:Fernando Trebien
1170:seems to prefer
1130:
1127:
1116:
1093:
1052:. The result of
1041:
1040:
1034:
956:
949:
943:
941:
924:
913:
887:
871:
837:
803:
802:
799:
796:
793:
772:
767:
766:
765:
756:
749:
748:
743:
735:
728:
698:
697:
694:
691:
688:
667:
660:
659:
654:
646:
639:
609:
608:
605:
602:
599:
572:
567:
566:
565:
556:
549:
548:
543:
535:
528:
498:
497:
494:
491:
488:
463:
458:
457:
447:
440:
439:
434:
426:
419:
402:
396:
395:
387:
338:This article is
335:
328:
286:
279:
271:
257:
256:
247:
226:
225:
211:
185:
177:
169:
155:
119:Article policies
40:
27:
21:
1697:
1696:
1692:
1691:
1690:
1688:
1687:
1686:
1597:
1596:
1582:
1560:
1535:
1533:
1505:
1501:
1490:
1484:
1479:
1478:
1414:
1411:
1394:
1391:
1357:
1275:
1222:
1128:
1125:
1089:
1079:
1038:
974:possibly useful
970:review articles
939:
937:
800:
797:
794:
791:
790:
768:
763:
761:
741:
695:
692:
689:
686:
685:
652:
606:
603:
600:
597:
596:
570:Medicine portal
568:
563:
561:
541:
495:
492:
489:
486:
485:
461:COVID-19 portal
459:
452:
432:
403:on Knowledge's
400:
379:broad consensus
342:British English
309:, any expected
273:
272:
267:
244:
145:
140:
139:
138:
115:
85:
23:
22:
18:Talk:BBIBP-CorV
15:
12:
11:
5:
1695:
1693:
1685:
1684:
1679:
1674:
1669:
1664:
1659:
1654:
1649:
1644:
1639:
1634:
1629:
1624:
1619:
1614:
1609:
1599:
1598:
1581:
1578:
1559:
1556:
1555:
1554:
1514:
1513:
1494:
1483:
1480:
1472:
1471:
1470:
1444:
1443:
1442:
1422:
1402:
1365:
1343:
1322:
1298:
1257:
1178:Sinopharm WIBP
1172:Sinopharm BIBP
1156:
1155:
1146:
1136:
1101:
1100:
1086:requested move
1080:
1078:
1075:
1073:
1069:
1068:
1054:the discussion
1042:
1030:
1029:
1028:
1027:
1013:
1000:
981:
957:
945:
944:
935:
912:
897:
883:
882:
870:
847:
833:
832:
829:
828:
825:
824:
817:Mid-importance
813:
807:
806:
804:
787:the discussion
774:
773:
757:
745:
744:
742:Midâimportance
736:
724:
723:
720:
719:
712:Mid-importance
708:
702:
701:
699:
682:the discussion
668:
656:
655:
653:Midâimportance
647:
635:
634:
631:
630:
623:Mid-importance
619:
613:
612:
610:
574:
573:
557:
545:
544:
542:Midâimportance
536:
524:
523:
520:
519:
512:Mid-importance
508:
502:
501:
499:
465:
464:
448:
436:
435:
433:Midâimportance
427:
415:
414:
408:
397:
383:
382:
336:
324:
323:
287:
275:
274:
265:
263:
262:
259:
258:
228:
227:
142:
141:
137:
136:
131:
126:
117:
116:
114:
113:
106:
101:
92:
86:
84:
83:
72:
63:
62:
59:
58:
52:
36:
35:
30:
24:
14:
13:
10:
9:
6:
4:
3:
2:
1694:
1683:
1680:
1678:
1675:
1673:
1670:
1668:
1665:
1663:
1660:
1658:
1655:
1653:
1650:
1648:
1645:
1643:
1640:
1638:
1635:
1633:
1630:
1628:
1625:
1623:
1620:
1618:
1615:
1613:
1610:
1608:
1605:
1604:
1602:
1595:
1594:
1590:
1586:
1579:
1577:
1576:
1572:
1568:
1567:Benedikt.ebli
1563:
1557:
1553:
1549:
1545:
1541:
1532:
1531:
1530:
1529:
1525:
1521:
1511:
1508:parameter to
1499:
1495:
1488:
1487:
1481:
1476:
1469:
1465:
1461:
1457:
1453:
1449:
1445:
1440:
1436:
1432:
1428:
1423:
1420:
1417:
1408:
1403:
1400:
1397:
1388:
1383:
1382:
1381:
1377:
1373:
1369:
1366:
1364:
1360:
1355:
1351:
1347:
1344:
1342:
1338:
1334:
1330:
1326:
1323:
1321:
1317:
1313:
1309:
1305:
1302:
1299:
1297:
1292:
1290:contributions
1284:
1278:
1273:
1269:
1265:
1261:
1258:
1256:
1252:
1248:
1244:
1240:
1236:
1233:
1232:
1231:
1229:
1225:
1221:
1220:
1213:
1209:
1205:
1201:
1197:
1193:
1189:
1185:
1181:
1179:
1175:
1173:
1169:
1165:
1161:
1154:
1150:
1147:
1145:
1141:
1138:
1137:
1135:
1134:
1131:
1120:
1114:
1112:
1108:
1099:
1097:
1092:
1087:
1082:
1081:
1076:
1074:
1066:
1065:
1061:
1055:
1051:
1047:
1043:
1036:
1035:
1026:
1025:
1020:
1019:
1014:
1011:
1010:
1005:
1004:TRIP database
1001:
998:
997:
992:
991:
986:
983:
982:
979:
975:
971:
967:
966:
961:
960:Ideal sources
958:
955:
951:
950:
942:
936:
932:
928:
921:
917:
910:
906:
902:
898:
893:
889:
888:
879:
875:
868:
864:
860:
856:
852:
848:
843:
839:
838:
822:
818:
812:
809:
808:
805:
788:
784:
780:
779:
771:
760:
758:
755:
751:
750:
746:
740:
737:
734:
730:
717:
713:
707:
704:
703:
700:
683:
679:
675:
674:
669:
666:
662:
661:
657:
651:
648:
645:
641:
628:
624:
618:
615:
614:
611:
594:
593:
588:
584:
580:
579:
571:
560:
558:
555:
551:
550:
546:
540:
537:
534:
530:
517:
513:
507:
504:
503:
500:
483:
479:
475:
471:
470:
462:
456:
451:
449:
446:
442:
441:
437:
431:
428:
425:
421:
416:
412:
406:
398:
394:
389:
388:
380:
376:
372:
368:
364:
360:
356:
352:
348:
344:
343:
337:
334:
330:
329:
322:
320:
316:
312:
308:
303:
301:
297:
293:
288:
285:
281:
280:
261:
260:
255:
251:
243:
239:
236:
234:
230:
229:
224:
220:
217:
214:
210:
206:
203:
200:
197:
196:ScienceDirect
194:
191:
188:
184:
180:
176:
172:
168:
164:
161:
158:
154:
148:
144:
143:
135:
134:Verifiability
132:
130:
127:
125:
122:
121:
120:
111:
107:
105:
102:
100:
96:
93:
91:
88:
87:
81:
77:
76:Learn to edit
73:
70:
65:
64:
61:
60:
56:
50:
46:
42:
41:
34:
31:
29:
28:
19:
1583:
1564:
1561:
1539:
1517:
1509:
1498:edit request
1474:
1460:WhatamIdoing
1447:
1367:
1345:
1333:Abrilando232
1324:
1307:
1303:
1300:
1259:
1234:
1218:
1217:
1203:
1195:
1191:
1187:
1183:
1177:
1171:
1158:â Following
1157:
1104:
1102:
1090:
1083:
1072:
1057:
1022:
1016:
1007:
994:
988:
977:
973:
963:
959:
915:
900:
873:
854:
850:
816:
776:
770:China portal
711:
687:Pharmacology
678:Pharmacology
671:
650:Pharmacology
622:
590:
576:
511:
467:
411:WikiProjects
366:
362:
358:
354:
350:
346:
339:
304:
289:
249:
231:
218:
212:
204:
198:
192:
186:
178:
170:
162:
156:
146:
118:
43:This is the
1372:Ozzie10aaaa
1359:Dđ¶ggy54321
1224:Dđ¶ggy54321
1160:WP:MEDTITLE
1096:move review
867:Graphic Lab
340:written in
55:not a forum
1601:Categories
1502:|answered=
1412:Shibboleth
1392:Shibboleth
1219:Relisting.
1188:BBIBP-CorV
1140:BBIBP-CorV
1126:Shibboleth
993:(limit to
300:designated
1585:Reza nava
1260:Weak move
1200:WIBP-CorV
1192:WIBP-CorV
1164:WP:MEDORG
1149:WIBP-CorV
1105:Moved to
1058:Moved to
1006:provides
987:provides
351:travelled
313:, or any
112:if needed
95:Be polite
45:talk page
1301:Comment.
1237:I think
1235:Comment.
905:included
859:included
855:diagrams
598:Medicine
539:Medicine
487:COVID-19
474:COVID-19
430:COVID-19
363:artefact
296:COVID-19
233:Archives
202:Springer
167:Cochrane
80:get help
53:This is
51:article.
1448:support
1368:support
1325:Support
1277:hueman1
819:on the
714:on the
625:on the
514:on the
401:C-class
367:analyse
359:defence
250:90Â days
1425:Note:
1405:Note:
1385:Note:
1166:, the
985:PubMed
940:Upload
931:Flickr
407:scale.
355:centre
347:colour
190:OpenMD
160:PubMed
1506:|ans=
1496:This
1184:BBIBP
1182:over
1046:moved
792:China
783:China
739:China
238:Index
216:Wiley
108:Seek
1589:talk
1571:talk
1548:talk
1540:Done
1524:talk
1464:talk
1454:and
1435:talk
1376:talk
1352:and
1337:talk
1327:per
1316:talk
1306:and
1282:talk
1266:and
1251:talk
1241:and
1212:talk
1190:and
1176:and
1162:and
1109:and
1062:and
1056:was
1021:and
1002:The
925:The
901:logo
478:join
290:The
209:Trip
183:Gale
175:DOAJ
97:and
1504:or
1458:.
1415:ink
1395:ink
1262:to
1129:ink
1048:to
1024:CDC
903:be
857:be
853:or
811:Mid
706:Mid
617:Mid
506:Mid
223:TWL
1603::
1591:)
1573:)
1550:)
1526:)
1510:no
1466:)
1446:I
1437:)
1378:)
1339:)
1331:.
1318:)
1253:)
1216:â
1151:â
1142:â
1123:â
1088:.
922:.
880:.
869:.
365:,
361:,
357:,
353:,
349:,
248::
240:,
78:;
1587:(
1569:(
1546:(
1522:(
1462:(
1433:(
1374:(
1335:(
1314:(
1293:)
1286:âą
1279:(
1249:(
1210:(
1186:/
1121:)
1117:(
1113:.
1067:.
1012:.
999:)
980:.
911:.
823:.
718:.
629:.
595:.
518:.
484:.
413:.
381:.
242:1
235::
219:·
213:·
205:·
199:·
193:·
187:·
179:·
171:·
163:·
157:·
82:.
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.